VoxelS.A.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-08-02
Share capital
10 502 600,00 PLN
Activity description

Voxel is a network of diagnostic centers specializing in radiology, nuclear medicine, and advanced technology. The company offers various imaging tests, including CT scans, MRI, PET-CT, SPECT, and fusion biopsy for prostate cancer, as well as treatments like radiosynovectomy and isotope therapy for joint conditions. Voxel has been operating since 2005 and provides online registration for diagnostic examinations.

Registered address
Wielicka 265, 30-663 Kraków, Poland
Website
voxel.plWebsite active
Email
Phone
Social media
Electronic delivery address
AE:PL-23931-31079-GCEDG-25

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 147.00
-0.40 (-0.27%)
144.00146.00148.00147.0010:0012:0014:0016:00
Open
PLN 148.40
High
PLN 148.80
Low
PLN 144.20
Volume
8.56K
Avg. vol.
6.14K
Market cap
PLN 1.54B
P/E ratio
12.41
EPS
PLN 11.85
Shares outstanding
10.5M
52-week
PLN 140.00 – 148.80
Dividend yield
1.70%
Dividend
PLN 2.50
Ex dividend date
Sep 29, 2026
ISIN
PLVOXEL00014
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 49.92mUSD 11.66mUSD 8.79m
Q1 2026USD 42.46mUSD 11.48mUSD 8.62m
Q4 2025USD 39.08mUSD 8.51mUSD 6.23m
Q3 2025USD 35.90mUSD 9.21mUSD 6.92m

Results for Q3 2026:Nov 26, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 94.05mMedianUSD 424.58kAverageUSD 1.68m
Net profit
This companyUSD 10.23mMedianUSD 13.22kAverageUSD 129.73k
Operating costs
This companyUSD 76.51mMedianUSD 377.37kAverageUSD 1.50m
Assets
This companyUSD 104.83mMedianUSD 168.61kAverageUSD 1.47m

News

Computed tomography in Czeladź – short examination dates

Maintenance work – temporary unavailability of online services

Maintenance work – temporary unavailability of online services

Fast appointments for PET-CT PSMA and PET-CT DOTA tests in Krakow

Fast appointments for PET-CT PSMA and PET-CT DOTA tests in Krakow

Planned Changes for Oncology Patients

Planned Changes for Oncology Patients

Corpus Christi 2026 – Working Hours

Corpus Christi 2026 – Working Hours

VOXEL S.A. Information

VOXEL S.A. Information

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-07-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jan 22, 2019Other notice
Dec 10, 2015Other notice
Apr 29, 2013Commercial Companies Code notice
Nov 30, 2012Other notice

Public aid

8 public aid cases recorded, with a total value of $2,120,126.

PurposeGross amount
Aid for research and development projects: industrial research
$914.7K
Aid for research and development projects: experimental development
$199.2K
Aid for research and development projects: experimental development
$329.8K

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $1,011,234.

ProjectEU co-financing
Przeprowadzenie prac badawczo-rozwojowych mających na celu wdrożenie innowacji procesowej opartej o sztuczną inteligencję w pracowniach diagnostyki obrazowej MRI
$329.9K
Rozbudowa działu B+R w celuprowadzenia prac nad nowymi radiofarmaceutykami
$221.6K
Przeprowadzenie prac rozwojowych mających na celu wdrożenie innowacyjnej technologii nowej linii radiofarmaceutyków
$403.4K

Tenders

35 tenders recorded as contractor: 7 national ($808,878) and 28 EU ($24,843,251).

SubjectAmount
Dostawa materiałów radioizotopowych
–
Udzielanie świadczeń w zakresie badań pet TK oraz pet TK z choliną – w rozpoznaniach onkologicznych z zastosowaniem radiofarmaceutyków z grupy i i II na potrzeby 5 WSZKzP SPZOZ w Krakowie
–
Wykonywanie badań obrazowych
–

Public sector contracts

Voxel is the contractor in 7 public sector contracts, worth PLN 8.15m in total. They were signed with 6 public buyers.

Public buyerValue
5 Wojskowy Szpital Kliniczny z Polikliniką-Samodzielny Publiczny Zakład Opieki Zdrowotnej w KrakowiePLN 994,932
Wojewódzki Ośrodek Lecznictwa Odwykowego I Zakład Opiekuńczo-Leczniczy w GorzycachPLN 650.00
Dolnośląskie Centrum Onkologii, Pulmonologii I HematologiiPLN 5,963,600
Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w KatowicachPLN 31,650
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu MedycznegoPLN 308,900

Public procurement disputes (KIO)

Voxel has been a party to 16 cases before the National Appeal Chamber (since 2013). It filed 9 appeals (3 upheld, 5 dismissed, 1 discontinued). In 7 cases it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
Mar 21, 2025KIO 734/25Participant (on authority's side)Wielkopolskie Centrum Onkologii w PoznaniuDismissed
Oct 2, 2023KIO 2814/23AppellantPaństwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji w WarszawieDiscontinued
Jun 14, 2022KIO 1449/22AppellantDolnośląskie Centrum Onkologii, Pulmonologii i HematologiiAuthority accepted the complaints
Apr 17, 2018KIO 551/18AppellantSamodzielny Publiczny Szpital Kliniczny nr 4 w LublinieDismissed
Apr 12, 2018KIO 556/18AppellantSamodzielny Publiczny Zespół Opieki Zdrowotnej Zespół Szpitali Miejskich w ChorzowieUpheld

National Health Fund (NFZ) contracts

Voxel has been an NFZ healthcare provider since 2008. In 2026 it is performing 22 contracts with a total value of USD 65.41m. All its contracts were worth USD 482.92m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Ambulatoryjna opieka specjalistycznamałopolskie1USD 9.82m
Ambulatoryjna opieka specjalistycznaśląskie1USD 8.83m
Świadczenia zdrowotne kontraktowane odrębnieśląskie1USD 7.04m
Świadczenia zdrowotne kontraktowane odrębniełódzkie1USD 6.50m
Ambulatoryjna opieka specjalistycznapodkarpackie1USD 4.69m

Trademarks

Voxel holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2009.

MarkProtected until
voxelMay 11, 2029

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Jarosław Furdal – President of the Management Board
Grzegorz Rutkowski – Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to submit declarations of will and sign documents on behalf of the company.

Supervisory board

Martyna Liszka Białek – Supervisory Board Member
Jakub Jan Kowalik – Supervisory Board Member
Vladimír Ježík – Supervisory Board Member
Magdalena Katarzyna Pietras – Supervisory Board Member
Wojciech Tomasz Napiórkowski – Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Voxel.

Subsidiaries

NameStake
AlterisS.A.
100%
Dicellasp. z o.o.
21.875%
Exira Gamma Knifesp. z o.o.
100%

Capital group

NameOwnership
Inwestycje sp z o.o
100%
Gamma Knife sp. z o.o
100%
Powiśle sp. z o.o
63.73%

Competitors

Name
LUX Med Onkologiasp. z o.o.
Synevosp. z o.o.
Affideasp. z o.o.
ICZ Healthcaresp. z o.o.
Pabianickie Centrum Medycznesp. z o.o.
Centrum Medyczne Medicasp. z o.o.
Nowy Szpitalsp. z o.o.
Tomma Diagnostyka ObrazowaS.A.
Affidea Onkoterapiasp. z o.o.
NU - Med GrupaS.A.

Change history

DateEvent
2025-09-05PKD change
2019-10-03PKD change
2013-07-31Share capital change
2013-04-18Share capital change
2013-03-15PKD change

FAQ

Last updated: 2026-07-31